Welcome to LookChem.com Sign In|Join Free

CAS

  • or

164290-83-9

Post Buying Request

164290-83-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

164290-83-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 164290-83-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,4,2,9 and 0 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 164290-83:
(8*1)+(7*6)+(6*4)+(5*2)+(4*9)+(3*0)+(2*8)+(1*3)=139
139 % 10 = 9
So 164290-83-9 is a valid CAS Registry Number.

164290-83-9Relevant articles and documents

Regioselective Synthesis of 2° Amides Using Visible-Light-Induced Photoredox-Catalyzed Nonaqueous Oxidative C-N Cleavage of N, N-Dibenzylanilines

Neerathilingam, Nalladhambi,Bhargava Reddy, Mandapati,Anandhan, Ramasamy

supporting information, p. 15117 - 15127 (2021/10/25)

A visible-light-driven photoredox-catalyzed nonaqueous oxidative C-N cleavage of N,N-dibenzylanilines to 2° amides is reported. Further, we have applied this protocol on 2-(dibenzylamino)benzamide to afford quinazolinones with (NH4)2S2O8 as an additive. Mechanistic studies imply that the reaction might undergo in situ generation of α-amino radical to imine by C-N bond cleavage followed by the addition of superoxide ion to form amides.

Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism

Roy, Swarnali,Mukherjee, Ayan,Paul, Barnali,Rahaman, Oindrila,Roy, Shounak,Maithri, Gundaram,Ramya, Bandaru,Pal, Sourav,Ganguly, Dipyaman,Talukdar, Arindam

, p. 334 - 347 (2017/04/26)

Toll-like receptor 9 (TLR9) is a major therapeutic target for numerous inflammatory disorders. Development of small molecule inhibitors for TLR9 remains largely empirical due to lack of structural understanding of potential TLR9 antagonism by small molecules and due to the unusual topology of the ligand binding surface of the receptor. To develop a structural model for rational design of small molecule TLR9 antagonists, an enhanced homology model of human TLR9 (hTLR9) was constructed. Binding mode analysis of a series of molecules having characteristic molecular geometry, flexibility and basicity was conducted based on crystal structure of the inhibitory DNA (iDNA) bound to horse and bovine TLR9. Interaction with specific amino acid residues in four leucine rich repeat (LRR) regions of TLR9 was identified to be critical for antagonism by small molecules. The biological validation of TLR9 antagonism and its correlation with probe-receptor interactions led to a reliable model that could be used for development of novel small molecules with potent TLR9 antagonism (IC50 30–100?nM) with excellent selectivity against TLR7.

Thermally induced cyclization of electron-rich N-arylthiobenzamides to benzothiazoles

Barrett, Oscene V.,Downer-Riley, Nadale K.,Jackson, Yvette A.

experimental part, p. 2579 - 2586 (2012/09/07)

Heating N-(2-methoxyphenyl)benzenecarbothioamides in refluxing nitrobenzene for 24 hours gives the corresponding benzothiazoles with intramolecular ipso substitution of the ortho-methoxy substituent. The thermal cyclization of various other N-arylthiobenzamides is also explored. Georg Thieme Verlag Stuttgart · New York.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 164290-83-9